Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Strategies for Meniscus Preservation and Regeneration: From the Lab to Clinical Practice (Deadline: 28 August 2021)
- Stem Cell Biology of Myeloid Neoplasms 2.0 (Deadline: 30 August 2021)
- Advance in Drug-Drug Interactions 2.0 (Deadline: 31 August 2021)
- Protein–Protein Interactions, Latest Drug Development Advances (Deadline: 31 August 2021)
- hiPSC-Derived Cells as Models for Drug Discovery 2.0 (Deadline: 31 August 2021)
- Pharmacology of Neurodegenerative Diseases (Deadline: 31 August 2021)
- Cytotoxic Drugs in the Modern Era of Personalized Medicine: Are They Still of Value? (Deadline: 31 August 2021)
- Models of Drug Addiction: Translating Molecular Targets into Molecular Medicine (Deadline: 31 August 2021)
- Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk (Deadline: 31 August 2021)
- Endometriosis: Biological Targets and New Therapeutical Approaches (Deadline: 31 August 2021)
- Biological Interactions of Bioactive Natural Products (Deadline: 31 August 2021)
- Mesenchymal Stem Cells and Their Derived Products as an Innovative Therapeutic Strategy in Acute Clinical Settings (Deadline: 15 September 2021)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis (Deadline: 26 September 2021)
- The Response to Drugs and Mechanisms of Resistance to Treatment in Severe Asthma (Deadline: 28 September 2021)
- New Drugs for Breast Cancer Treatment (Deadline: 30 September 2021)
- Oligonucleotide, Therapy, and Applications 2.0 (Deadline: 30 September 2021)
- Biological Properties of Medicinal Plants (Deadline: 30 September 2021)
- Molecular Mechanisms and Therapies for Kidney Diseases (Deadline: 30 September 2021)
- ncRNAS in Therapeutics (Deadline: 30 September 2021)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers (Deadline: 30 September 2021)
- Application Progress of Liposomes in Drug Development (Deadline: 30 September 2021)
- Molecular Mechanisms of Mood Stabilizers (Deadline: 30 September 2021)
- New Frontiers in Molecular Mechanisms and Therapies in Neurological Diseases (Deadline: 30 September 2021)
- Adenovirus: Enduring Toolbox for Basic and Applied Research (Deadline: 30 September 2021)
- Targeting Monoamine Oxidases: From Enzymatic Function to Pharmaceutical Use (Deadline: 30 September 2021)
- ADME of Novel Modalities Synopsis (Deadline: 12 October 2021)
- The Molecular Pharmaceutics and Drug Delivery (Deadline: 22 October 2021)
- Advances in Molecular Activity of Potential Drugs (Deadline: 25 October 2021)
- Protein Structure–Function Relationships (Deadline: 25 October 2021)
- The Discovery and Development of Cisplatin (Deadline: 27 October 2021)
- Molecular Pharmacology of Fatty Acids and Fatty Acid Derivatives (Deadline: 30 October 2021)
- Beyond the Primary Infarction: Focus on Mechanisms Related to Secondary Neurodegeneration after Stroke (Deadline: 31 October 2021)
- Recent Advances in B Cells: Signal Transduction and Therapeutic Potential (Deadline: 31 October 2021)
- Recent Applications of PLGA-Based Nanoparticles in Drug Delivery (Deadline: 31 October 2021)
- Drug Resistance-Associated Proteins in Cancer (Deadline: 31 October 2021)
- COVID-19 Innovative Drug Treatments: Looking Outside of Plato’s Cave (Deadline: 31 October 2021)
- Cellular Senescence and the Inflammatory Response in Health and Disease (Deadline: 31 October 2021)
- Non-coding RNAs as New Drug Targets (Deadline: 3 November 2021)
- Nutraceuticals in Human Diseases: Metabolism and Interactions (Deadline: 25 November 2021)
- Natural Bioactive Compounds for Human Health (Deadline: 25 November 2021)
- The Pharmacology of Neurotransmission: Focus on Synaptic Alterations during Neurodegeneration and Treatments 2.0 (Deadline: 28 November 2021)
- Bridging the Gap between the Clinical and Regulatory Use of Plasma Rich in Growth Factors. Where Are We? (Deadline: 30 November 2021)
- The Dysbiotic Vaginal Microbiome: Pathogenesis and Therapeutic Opportunities (Deadline: 30 November 2021)
- Pharmacogenomics 2.0 (Deadline: 30 November 2021)
- Molecular Pathogenesis and Cellular-Based Therapies for Thrombocytopenia (Deadline: 30 November 2021)
- The Collagen Connection (Deadline: 30 November 2021)
- Curcumin Derivatives and Curcuminoids as Theranostic Agents in Alzheimer’s Disease (Deadline: 30 November 2021)
- Pharmacological Strategies for Neuroinflammation in Brain Injury (Deadline: 30 November 2021)
- Nanoformulations and Nano Drug Delivery (Deadline: 30 November 2021)
- Advances on Chelation and Chelator Metal Complexes in Medicine (Deadline: 30 November 2021)
- Recent Advances in Diabetic Liver Disease (Deadline: 30 November 2021)
- Recent Advances of Natural Chemical as Kinase Inhibitor (Deadline: 29 December 2021)
- Primary Ciliary Dyskinesia: Genetics, Molecular Mechanisms, Diagnostic and Therapeutic Perspectives (Deadline: 30 December 2021)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity (Deadline: 30 December 2021)
- Molecular Therapy Targeting Cancer Specific Signal Pathways (Deadline: 30 December 2021)
- Hormone Receptors and Signaling in Breast Cancer: Novel Targets and Therapeutic Challenges (Deadline: 31 December 2021)
- Endogenous Gaseous Signaling Molecules: Their Mechanism(s) of Action and Pharmacological Effects (Deadline: 31 December 2021)
- Advances in Photopharmacology (Deadline: 31 December 2021)
- Effects of Drugs of Abuse on the Blood-Brain Barrier (Deadline: 31 December 2021)
- Advances in Nanostructured Materials between Pharmaceutics and Biomedicine 2.0 (Deadline: 31 December 2021)
- Tryptophan in Nutrition and Health 2.0 (Deadline: 31 December 2021)
- Potential Biomedical and Pharmacological Uses of Plant Essential Oils: Molecular Mechanisms Involved in Their Activity (Deadline: 31 December 2021)
- Bioactive Molecules and Health (Deadline: 31 December 2021)
- Pharmacological Plasticity (Deadline: 31 December 2021)
- Cell Therapy Approaches for Diabetes (Deadline: 31 December 2021)
- 5-ISPMF Special Issue: Phytochemicals in Cardiovascular and Metabolic Diseases-Molecular Pharmacology and Therapeutic Potential (Deadline: 31 January 2022)
- Natural Product Pharmacology (Deadline: 31 January 2022)
- Biomolecules for Nanodelivery (Deadline: 31 January 2022)
- Research Progress of Platelet Metabolism in Regulating Platelet Function and Thrombosis (Deadline: 31 January 2022)
- Natural Product-Based Drug Discovery for COVID-19 Disease (Deadline: 31 January 2022)
- Recent Advances in Antibody Therapeutics 2.0 (Deadline: 28 February 2022)
- Lipid Signaling Pathways in Drug Delivery and Therapeutics (Deadline: 28 February 2022)
- The Magnificent World of Induced Pluripotent Stem Cell-Derived Cardiomyocytes (Deadline: 28 February 2022)
- Recent Advances of Bioactive Compounds in Pharmaceutical Designs for Treating Skin Diseases (Deadline: 31 March 2022)
- Neuropharmacology & Neurodegenerative Diseases (Deadline: 31 March 2022)
- Endogenous Opioids in Stem Cell Development, Stress, and Aging (Deadline: 31 March 2022)
- Is Vesicular Therapy the Newcomer That Matters for the Medicine of Tomorrow? (Deadline: 30 April 2022)
- Multi-Target Directed Ligands in Drug Development (Deadline: 31 December 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
